Source: Playing catch-up in the next-gen psoriasis market, Eli Lilly is going all out with its first ad campaign for Taltz, promising “a chance at completely clear skin.” In Lilly’s crosshairs? Novartis’ Cosentyx, which has had a 14-month lead in getting to market first with an IL-17 inhibitor. In the…...